tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Oxford Biomedica Reports Strong 2024 Financial Performance
Company AnnouncementsOxford Biomedica Reports Strong 2024 Financial Performance
3d ago
Oxford Biomedica’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Oxford Biomedica’s Earnings Call Highlights Growth and Challenges
3d ago
Oxford Biomedica prepares statements on ‘going concern basis’
PremiumThe Fly
Oxford Biomedica prepares statements on ‘going concern basis’
4d ago
Oxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last year
PremiumThe Fly
Oxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last year
4d ago
Oxford Biomedica vice chair Stuart Henderson to retire
PremiumThe Fly
Oxford Biomedica vice chair Stuart Henderson to retire
4d ago
Oxford Biomedica sees FY25 revenue GBP 160M-GBP 170M
PremiumThe FlyOxford Biomedica sees FY25 revenue GBP 160M-GBP 170M
4d ago
Oxford BioMedica: Promising Growth and Attractive Valuation Drive Buy Rating
Premium
Ratings
Oxford BioMedica: Promising Growth and Attractive Valuation Drive Buy Rating
4d ago
Oxford BioMedica Reports Robust 2024 Financial Performance and Strategic Expansion
Premium
Company Announcements
Oxford BioMedica Reports Robust 2024 Financial Performance and Strategic Expansion
4d ago
Briarwood Chase Increases Stake in Oxford BioMedica
PremiumCompany Announcements
Briarwood Chase Increases Stake in Oxford BioMedica
9d ago
Oxford Biomedica’s Colin Bond Joins Faron Pharmaceuticals as Non-Executive Director
PremiumCompany Announcements
Oxford Biomedica’s Colin Bond Joins Faron Pharmaceuticals as Non-Executive Director
17d ago
Oxford Biomedica Announces Total Voting Rights
PremiumCompany Announcements
Oxford Biomedica Announces Total Voting Rights
1M ago
Oxford Biomedica to Present at Global Healthcare Conference
PremiumCompany Announcements
Oxford Biomedica to Present at Global Healthcare Conference
2M ago
M&G Plc Increases Stake in Oxford BioMedica
PremiumCompany AnnouncementsM&G Plc Increases Stake in Oxford BioMedica
2M ago
Oxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trial
Premium
The Fly
Oxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trial
2M ago
Oxford Biomedica Supports Boehringer Ingelheim’s Cystic Fibrosis Gene Therapy Trial
Premium
Company Announcements
Oxford Biomedica Supports Boehringer Ingelheim’s Cystic Fibrosis Gene Therapy Trial
2M ago
Oxford BioMedica Announces Change in Major Holdings
PremiumCompany Announcements
Oxford BioMedica Announces Change in Major Holdings
2M ago
Oxford BioMedica: Poised for Growth with Strong Financial Trajectory and Attractive Valuation
PremiumRatings
Oxford BioMedica: Poised for Growth with Strong Financial Trajectory and Attractive Valuation
2M ago
Oxford BioMedica’s Strong 2024 Performance and Promising 2025 Outlook
PremiumCompany Announcements
Oxford BioMedica’s Strong 2024 Performance and Promising 2025 Outlook
2M ago
Oxford Biomedica appoints joint corporate broker, joint financial advisor
PremiumThe Fly
Oxford Biomedica appoints joint corporate broker, joint financial advisor
2M ago
Oxford BioMedica Strengthens Financial Advisory Team
PremiumCompany AnnouncementsOxford BioMedica Strengthens Financial Advisory Team
2M ago
Oxford BioMedica Announces Block Listing for Growth Initiatives
Premium
Company Announcements
Oxford BioMedica Announces Block Listing for Growth Initiatives
3M ago
Oxford BioMedica Sees Major Stake Acquisition by Briarwood Chase
Premium
Company Announcements
Oxford BioMedica Sees Major Stake Acquisition by Briarwood Chase
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >